VEGFR2, one of its two key receptors, is selectively expressed by Foxp3high CD4+ Tregs and VEGF-A has been shown to induce Treg proliferation in a VEGFR2-dependent manner in tumor-bearing mice and metastatic colorectal cancer patients (63, 64). Here, KDR is linked to metastatic colorectal cancer.